OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
Stocks in this Quantisnow insightHealth Care
Historical context for OKYO
Across the 8 sessions after earlier OKYO headlines, the stock closed higher 4 times and lower 3 times, with a median move of 6.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | OKYO | SPY |
|---|---|---|---|
| Dec 19, 2025 | OKYO Pharma to Ring the Opening Bell at Nasdaq | +8.6% | +0.6% |
| Dec 15, 2025 | OKYO Pharma Announces Chairman and Founder Acquires Shares | -8.3% | -0.2% |
| Dec 11, 2025 | OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain | +6.9% | +0.2% |
| Dec 8, 2025 | B. Riley Securities initiated coverage on OKYO Pharma with a new price target | +0.0% | -0.3% |
| Dec 3, 2025 | OKYO Pharma Announces Chairman and Founder Acquires Shares | -5.8% | +0.3% |
| Nov 21, 2025 | OKYO Pharma Announces Chairman and Founder Acquires Shares | +11.0% | +1.0% |
Quantisnow market dataNASDAQ
OKYO
OKYO Pharma Limited
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2022
Get push alerts for OKYO
Full OKYO profile on Quantisnow Follow OKYO and get a push notification the moment its next story breaks.